News
Launched MAUD 1.0 platform for AI-driven cyclic peptide design.
Company Context
- Revenue
- $2.1M in 2024 (Source: Getlatka)
- Market
- Biotech
- Stage
- Seed
Key Highlight
MENTEN AI appointed Andrea McNeal as VP of Business Development in October 2025.
More from MENTEN AI
More Biotech News
- ColossalColossal Biosciences Reawakens the Dire WolfMar 2026
- MinicircleKlotho Gene Therapy launching in 2026Mar 2026
- ColossalColossal Foundation Doubles Funding to $100MJan 2026
- ColossalColossal Foundation raised $50 millionDec 2025
- AetherRaised $15M to reindustrialize America with AI-designed proteinsDec 2025